← All Ocugen, INC filings

Ocugen, INC 8-K filings

NASDAQ
OCGN
Ocugen, INC
8-K: Ocugen Presents Clinical Showcase, Highlights Progress in Gene Therapy Programs
Ocugen presented a clinical showcase highlighting their gene therapy programs, including OCU400 for retinitis pigmentosa and Leber congenital amaurosis, and provided updates on their pipeline and market potential.